Please login to the form below

Not currently logged in
Email:
Password:

US senate

This page shows the latest US senate news and features for those working in and with pharma, biotech and healthcare.

Tit for tat as PBMs blame pharma for high drug prices

Tit for tat as PBMs blame pharma for high drug prices

US Senate turns its spotlight on 'middlemen'. Pharmacy benefit managers (PBMs) were challenged by the US Senate Finance Committee on their pricing practices yesterday, but laid the blame on pharmaceutical manufacturers.

Latest news

  • Senate grilling makes pharma CEOs squirm, but give little ground Senate grilling makes pharma CEOs squirm, but give little ground

    Yesterday’s much anticipated US Senate inquiry provided a welcome spectacle for anyone who enjoys seeing big pharma executives given a good scolding on their drug pricing tactics, but produced only ... They opposed the “international price index”

  • CEOs agree to Congressional grilling on US drug prices CEOs agree to Congressional grilling on US drug prices

    as part of a probe into US drug prices. Chair of the Senate committee on finance, Republican Charles Grassley is a long-time critic of pharma pricing policies, and announced the ... Big pharma’s leaders say they shouldn’t shoulder all of the blame,

  • Reference price bill tabled in US House and Senate Reference price bill tabled in US House and Senate

    Former US presidential candidate Bernie Sanders has introduced a bill in the Senate that would peg US prescription drugs cost at no more than the median price of medicines in Canada, ... The move comes two weeks after the US mid-terms saw the Republicans

  • Novartis rejects claims it misled Senate over Cohen links Novartis rejects claims it misled Senate over Cohen links

    Report says Novartis discussed drug-pricing with the President’s former ‘fixer’. A US Senate report has concluded that Novartis had a deeper relationship than it previously claimed with Donald ... According to the US Senate Health, Education, Labor

  • After Senate vote, Cures Act is en route to Obama for signature After Senate vote, Cures Act is en route to Obama for signature

    Legislation designed to make new therapies accessible to patients more quickly has been passed by the US Senate, with just a signature by President Obama now required before it comes into ... law. The US Senate voted 94 to 5 to approve the 21st Century

More from news
Approximately 2 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • The Orkambi blame game The Orkambi blame game

    The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... were ‘freeloading’ while high US prices provide the incentive

  • US health reforms US health reforms

    This leaves us with two possible scenarios: either Senate republicans fail to pass a repeal and replace bill altogether; or they pass a watered-down version of the House bill that ... is a freelance writer based in the Philadelphia metro area of the US.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...
Investing in our People
As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....

Infographics